CATALYST BIOSCIENCES, INC. - FORM 10-K - EX-32.1 - CERTIFICATION OF THE CEO PURSUANT TO 18 U.S.C. SECTION 1350 - March 11, 2011

Attached files

file filename
10-K - FORM 10-K - CATALYST BIOSCIENCES, INC.d10k.htm
EX-23.1 - CONSENT OF ERNST & YOUNG LLP - CATALYST BIOSCIENCES, INC.dex231.htm
EX-32.2 - CERTIFICATION OF THE CFO PURSUANT TO 18 U.S.C. SECTION 1350 - CATALYST BIOSCIENCES, INC.dex322.htm
EX-31.2 - CERTIFICATION OF THE CFO PURSUANT TO RULE 13A-14(A) AND 15D-14A - CATALYST BIOSCIENCES, INC.dex312.htm
EX-31.1 - CERTIFICATION OF THE CEO PURSUANT TO RULE 13A-14(A) AND 15D-14A - CATALYST BIOSCIENCES, INC.dex311.htm
EX-10.4(A) - TARGACEPT, INC. 2006 STOCK INCENTIVE PLAN - CATALYST BIOSCIENCES, INC.dex104a.htm
EX-10.19 - DESCRIPTION OF ANNUAL CASH INCENTIVE PROGRAM - CATALYST BIOSCIENCES, INC.dex1019.htm
EX-10.18 - EXCLUSIVE LICENSE AGREEMENT - CATALYST BIOSCIENCES, INC.dex1018.htm

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Targacept, Inc. (the “Company”) for the period ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, J. Donald deBethizy, President and Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 11, 2011     By:   /S/    J. DONALD DEBETHIZY        
        J. Donald deBethizy
        President and Chief Executive Officer

CATALYST BIOSCIENCES, INC. Reports

Also read